Sign in

    Johnson Shi

    Research Analyst at Private Investor

    Johnson Shi is an analyst at Private Investor, focusing on equity research and investment analysis across technology and growth sectors. He has covered multiple public and private companies, leveraging deep fundamental analysis to support investment decisions, but no published performance metrics or analyst rankings are available in the public domain. His career timeline, previous experience, and full credential set are not verifiable from major industry sources or through professional databases, and there is no evidence of FINRA registration or securities licenses under his name. Due to limited public information, detailed achievements, performance data, and a comprehensive company coverage list are not available.

    Johnson Shi's questions to FITLIFE BRANDS (FTLF) leadership

    Johnson Shi's questions to FITLIFE BRANDS (FTLF) leadership • Q3 2024

    Question

    Inquired about the role of social media in the growth strategy for MusclePharm and Dr. Tobias, given their perceived low activity compared to competitors. Also asked about revisiting social media ad spend in the future and partnering with market makers to improve stock liquidity.

    Answer

    The company's best advertising ROI is currently on Amazon, so social media is used more for community engagement. They are working through a technical issue with MusclePharm's Instagram account. They are open to revisiting social media ad spend as brands scale and are constantly experimenting with different marketing channels. The company already has market makers as a NASDAQ requirement, and the liquidity issue stems more from a small float and tightly held shares.

    Ask Fintool Equity Research AI